您的位置: 首页 > 农业专利 > 详情页

THERAPIES CONJOINTES A DES FINS D'IMMUNOMODULATION
专利权人:
AURIGENE DISCOVERY TECHNOLOGIES LIMITED;CURIS, INC
发明人:
SASIKUMAR, POTTAYIL GOVINDAN NAIR,RAMACHANDRA, MURALIDHARA,RAMACHANDRA, RAGHUVEER KALLAJHARI,LAZORCHAK, ADAM S.,WYANT, TIMOTHY L.
申请号:
CA3081675
公开号:
CA3081675A1
申请日:
2018.10.31
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
The present disclosure relates to methods comprising administering compounds that inhibit VISTA and PD-1 (e.g., PD-1, PD-L1 or PD-L2) pathways with a compound that inhibits TIM-3 and PD-1 (e.g., PD-1, PD-L1 or PD-L2) pathways.The disclosure also relates to treatment of disorders by inhibiting an immunosuppressive signal induced by VISTA, TIM-3, PD-1, PD-L1, and/or PD-L2.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充